Endocrine Flashcards
Metabolic syndrome
People at high risk of diabetes and cardiovascular disease
Metabolic syndrome associated condition
Small dense LDL
Proinflammatory state
Hyperinsulinemia
Hyperuricemia
Chronic kidney disease
Dementia/cognitive decline
Steatosis, fibrosis, cirrhosis
Insulin resistance
PCOS
Sleep apnea
Metabolic syndrome labs and tests to consider
Hemoglobin A1C
Lipid panel
BMP
C-reactive protein
Liver panel
TSH
Uric acid
ECG
Vascular ultrasound
Stress test
Sleep study
Underweight BMI
<18.5
Normal BMI
18.5-24.9
Overweight BMI
25-29.9
Obesity class 1
30-34.9
Obesity class 2
35-39.9
Extreme obesity (class 3)
> 40
Man waist size at risk of obesity
> 40
Woman waist size at risk of obesity
> 35
Man waist to hip ratio at risk of obesity
> 1
Woman waist to hip ratio at risk of obesity
> 0.85
Leptin
Tells brain you’re full
Decrease when you’re fat
Grhelin
Tells you you’re hungry
BMI indications for weight loss meds
> 27 with comorbidities
30
Phentermine
Weight loss drug
Adrenergic agonist
Decrease appetite
Short term use
Orlistat
Weight loss drug
Inhibits intestinal lipase
Causes diarrhea if eat lots of fat
Phentermine/topiramate
Weight loss drug
GABA modulation
Decreases appetitie and speeds metabolism
TERATOGENIC
Naltrexonebupropion
Weight loss drug
Appetite suppression
Two tabs twice daily over four weeks
Liraglutide
Weight loss drug
GLP-1 receptor agonist
Increases satiety
Daily injectable
Semaglutide
Weight loss drug
GLP-1 receptor agonist
INcreases satiety
Weekly injectable
Contraindicated for pts with pancreatitis or thyroid C-cell tumor hx
Tirzepatide
Weight loss drug
Dual GLP-1 agonist and GIP
ONce weekly subcutaneous injection
Fasting ansd post-prandial glucose
Lowers A1C by more than 2%
Common adverse effects of GLP-1 receptor agonist
Nausea
Vomiting
Diarrhea
Constipation